2013 Maryland Code
§ 5-405 - Schedule IV
(a) Schedule IV consists of each controlled dangerous substance:
(1) listed in this section;
(2) added to Schedule IV by the Department under § 5-202(b) of this title; or
(3) designated as a Schedule IV controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.
(b) Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(4) chloral betaine;
(5) chloral hydrate;
(43) tetrazepam; and
(c) Substances listed in Schedule IV include:
(1) a material, compound, mixture, or preparation that contains fenfluramine; and
(2) if its existence is possible:
(i) a salt of fenfluramine;
(ii) an optical, position, or geometric isomer of fenfluramine; and
(iii) a salt of an isomer of fenfluramine.
(d) Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(2) pemoline, including organometallic complexes and their chelates; and
(e) By regulation, the Department may exempt from this section a compound, mixture, or preparation that contains a depressant substance listed in subsection (b) of this section if:
(1) the compound, mixture, or preparation contains an active medicinal ingredient that does not have a depressant effect on the central nervous system; and
(2) the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.
(f) The Department may not add a substance to Schedule IV under § 5-202 of this title unless the Department finds that:
(1) the substance has a low potential for abuse relative to the substances listed in Schedule III;
(2) the substance has currently accepted medical use in treatment in the United States; and
(3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.
Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.